动物源与全合成脱细胞真皮基质在重建外科中的比较分析:临床、美学与经济指标考察
单中心回顾性研究比较2011-2022年26例软组织创面分别使用全合成NovoSorb可生物降解临时基质(BTM)或动物源Integra真皮再生模板(IDRT)的临床、美学与经济结局。BTM组手术时间、术后住院、随访次数、完全闭合时间、感染率、增生率及温哥华瘢痕量表调整分数均低于IDRT组,但翻修手术更频繁、每平方厘米平均利润更低。
要点
- BTM组手术时间1.632±0.571小时,显著短于IDRT组5.282±5.102小时(P=0.011)。
- BTM组感染率0.0%,低于IDRT组36.4%(P=0.022);增生率26.7%低于81.8%(P=0.015)。
- BTM组翻修手术显著更频繁(P<0.001),每平方厘米平均利润$10.63低于IDRT $22.53(P<0.001)。
核心结论
- 尽管每平方厘米净利润可能有利于IDRT,但BTM在缩短住院、手术时间、随访次数及降低翻修手术率方面的辅助获益对总体成本效益有实质贡献。
- BTM的使用反映更高效的资源利用和潜在成本节约,符合强调价值导向和以患者为中心的医疗趋势。
研究设计与样本
- 单中心回顾性研究,比较2011-2022年间26例患者使用BTM(57.7%)或IDRT(42.3%)治疗软组织创面的结局。
主要发现
- BTM组平均手术时间1.632±0.571小时,IDRT组5.282±5.102小时(P=0.011)。
- BTM组术后住院中位时间0.95天,IDRT组6.60天(P=0.003);BTM组随访次数中位数5次,IDRT组14次(P=0.012)。
- BTM组完全创面闭合中位时间46.96天,IDRT组118.91天(P=0.011);BTM组感染率0.0%,IDRT组36.4%(P=0.022)。
- IDRT组创面增生率81.8%,BTM组26.7%(P=0.015);BTM组翻修手术显著更频繁(P<0.001)。
- BTM组失败闭合(需一次或多次尝试)风险6.7%,IDRT组26.7%(P=0.003);BTM组温哥华瘢痕量表调整分数均值0.279,IDRT组0.639(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The fully synthetic skin substitute, NovoSorb Biodegradable Temporizing Matrix (BTM), may be a cost-effective alternative to the animal-derived Integra Dermal Regeneration Template (IDRT). However, the current literature insufficiently compares the two. Therefore, our study compared clinical, aesthetic, and economic outcomes in treating soft tissue wounds with IDRT, an animal-derived template, vs BTM, a fully synthetic template. METHODS: Our single-center retrospective study compared outcomes of 26 patient cases treated with BTM (57.7%) or IDRT (42.3%) during 2011-2022. RESULTS: The mean surgery time was significantly shorter in BTM cases (1.632 ± 0.571 hours) compared with IDRT cases (5.282 ± 5.102 hours, P = 0.011). Median postoperative hospital stay was notably shorter for BTM placement than IDRT placement (0.95 vs 6.60 days, P = 0.003). The median postoperative follow-up length approached a shorter duration in the BTM group (P = 0.054); however, median follow-up visits were significantly lower in the BTM group compared with the IDRT group (5 vs 14, P = 0.012). The median duration for complete wound closure was shorter for BTM (46.96 vs 118.91 days, P = 0.011). Biodegradable Temporizing Matrix demonstrated a notably lower infection rate (0.0%) compared with IDRT (36.4%, P = 0.022). Integra Dermal Regeneration Template exhibited higher wound hypertrophy rates (81.8%) than BTM (26.7%, P = 0.015). Revisionary surgeries were significantly more frequent in the BTM group (P < 0.001). Failed closure, defined as requiring one or more attempts, exhibited a significant difference, with a higher risk in the IDRT group (26.7%) compared with BTM (6.7%, P = 0.003). Biodegradable Temporizing Matrix showed a lower mean Vancouver Scar Scale adjusted fraction (0.279) compared with IDRT (0.639, P < 0.001). Biodegradable Temporizing Matrix incurred lower costs compared with IDRT but displayed a lower mean profit per square centimeter ($10.63 vs $22.53, P < 0.001). CONCLUSION: Economically, although the net profit per square centimeter of dermal template may favor IDRT, the ancillary benefits associated with BTM in terms of reduced hospital stay, shorter surgery times, fewer follow-up visits, and lower revisionary surgery rates contribute substantially to overall cost-effectiveness. Biodegradable Temporizing Matrix use reflects more efficient resource use and potential cost savings, aligning with broader trends in healthcare emphasizing value-based and patient-centered care.
引用
- Olsen T, Ali-Khan S, Bell D, et al. Comparative Analysis of Animal-Derived vs Fully Synthetic Acellular Dermal Matrices in Reconstructive Surgery: An Examination of Clinical, Aesthetic, and Economic Measures. Ann Plast Surg. 2024. PMID: 38556669. doi:10.1097/SAP.0000000000003909
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。